Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05799391Phase 2Completed
Phase 2, randomised, double-blind trial in chronic pain (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Range of Motion at 2 weeks. Started Jul 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05799391.